Detalles de la búsqueda
1.
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
N Engl J Med
; 390(4): 326-337, 2024 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38078508
2.
Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy.
Br J Haematol
; 2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38867615
3.
Is it time for PET-guided therapy in follicular lymphoma?
Blood
; 139(11): 1631-1641, 2022 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34260714
4.
A five-year follow-up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial.
Br J Haematol
; 190(5): 736-740, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32236950
5.
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL.
Hematol Oncol
; 37(4): 352-359, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31385336
6.
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.
N Engl J Med
; 370(11): 997-1007, 2014 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-24450857
7.
Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.
Blood
; 126(18): 2110-7, 2015 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26316624
8.
Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cells.
J Immunol
; 194(5): 2439-46, 2015 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25632006
9.
Total proteome analysis identifies migration defects as a major pathogenetic factor in immunoglobulin heavy chain variable region (IGHV)-unmutated chronic lymphocytic leukemia.
Mol Cell Proteomics
; 14(4): 933-45, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25645933
10.
BH3 profiling and a toolkit of BH3-mimetic drugs predict anti-apoptotic dependence of cancer cells.
Br J Cancer
; 114(6): 638-41, 2016 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26954718
11.
NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome.
Br J Haematol
; 175(1): 43-54, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27378086
12.
Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial.
Lancet
; 385(9980): 1873-83, 2015 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25882396
13.
SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.
Blood
; 123(7): 1021-31, 2014 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-24335234
14.
CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia.
Blood
; 122(26): 4253-8, 2013 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-24128861
15.
Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial.
Haematologica
; 105(10): e519, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33054096
16.
Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial.
Haematologica
; 105(12): 2868-2871, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33256390
17.
Chemokine unresponsiveness of chronic lymphocytic leukemia cells results from impaired endosomal recycling of Rap1 and is associated with a distinctive type of immunological anergy.
J Immunol
; 191(3): 1496-504, 2013 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23804711
18.
Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia.
Br J Haematol
; 167(3): 346-55, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25040181
19.
Consultations about randomised controlled trials are shorter and less in-depth for socioeconomically disadvantaged patients compared to socioeconomically advantaged patients: qualitative analysis across three trials.
Trials
; 25(1): 382, 2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38872208
20.
Central nervous system plasmablastic lymphoma evolving from polyclonal plasmacytosis.
Br J Haematol
; 183(3): 345, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29984820